John Neis - Profile and Investment Details

Investor Profile

John Neis is a Venture Capital, Private Equity Firm, Investor based in Madison, Wisconsin, United States with a diverse investment portfolio that includes companies such as Elucent Medical, UpTo, Virent Energy Systems, EnsoData, Invenra, Celleration, Inviragen, IntraLase Corporation, Zystor, Third Wave Technologies, Chromatin, Thalchemy, Madison Vaccines, Alfalight, Nextt, InterSymbol Communications, NeuWave MedicalHealthMyne, Pattern Insight, Morgridge Institute for Research, TomoTherapy, FluGen, BlueWillow Biologics, Roche NimbleGen, Mithridion, Silatronix, NeuMoDx Molecular, Venture Investors, Corona Optical Systems, National Venture Capital Association, ReShape Lifesciences, Prevacept Infection Control, NERITES, Juventas Therapeutics, Promega, Neurovance, SoftSwitching Technologies, Health Scholars, SkySpecs, Delphinus Medical Technologies, Deltanoid Pharmaceuticals, TAI Diagnostics, ProCertus BioPharm, HistoSonics, Aerpio Pharmaceuticals, Eximis Surgical, Tissue Regeneration Systems, LensX Lasers, Incept, Cellectar Biosciences, Wisconsin Technology Council, Gala Biotech, Euthymics Bioscience, Netsocket, Akebia Therapeutics, . Over time, John Neis has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether John Neis is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Hospitals, Wellness, Women Founded, Investment Management, Energy, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Artificial Intelligence (AI), Robotics, Startups, Information Technology (IT), Marketplace, Analytics, Finance, Software, Biotechnology, Medical Devices, Hispanic / Latinx Founded, Electronic Health Records (EHR), Productivity Software, Clinical Trials, FinTech, Marketing, Health Diagnostics, Digital Health, Renewable Energy, Medical, Information Technology, B2B, Therapeutics, Health Tech, Molecular Diagnostics, Media and Entertainment, Machine Learning, Air Transportation, Pharmaceuticals, Healthcare Technology, Oncology may find it worthwhile to explore potential connections with John Neis, as their portfolio suggests a familiarity and interest in this area.

Understanding John Neis’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.